BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22706483)

  • 1. Non-small-cell lung cancer infiltrated with chronic myelomonocytic leukaemia: a molecular diagnostic challenge to recognise mixed cancers in a single biopsy.
    Koopman B; Hiddinga BI; Platteel I; Kluiver JL; Timens W; Mulder AB; van Doesum JA; Schuuring E; Diepstra A; van Kempen LC
    Histopathology; 2021 Jun; 78(7):1043-1046. PubMed ID: 33410163
    [No Abstract]   [Full Text] [Related]  

  • 2. Update in lung cancer and mesothelioma 2012.
    Powell CA; Halmos B; Nana-Sinkam SP
    Am J Respir Crit Care Med; 2013 Jul; 188(2):157-66. PubMed ID: 23855692
    [No Abstract]   [Full Text] [Related]  

  • 3. Squamous cell lung cancer: from tumor genomics to cancer therapeutics.
    Gandara DR; Hammerman PS; Sos ML; Lara PN; Hirsch FR
    Clin Cancer Res; 2015 May; 21(10):2236-43. PubMed ID: 25979930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems.
    Doumat G; Daher D; Zerdan MB; Nasra N; Bahmad HF; Recine M; Poppiti R
    Curr Oncol; 2023 Jan; 30(1):704-719. PubMed ID: 36661704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine.
    Soldera SV; Leighl NB
    Front Oncol; 2017; 7():50. PubMed ID: 28396848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between PD-L1 expression and initial brain metastasis in patients with non-small cell lung cancer and its clinical implications.
    Lee K; Choi YJ; Kim JS; Kim DS; Lee SY; Shin BK; Kang EJ
    Thorac Cancer; 2021 Aug; 12(15):2143-2150. PubMed ID: 34121347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.
    Taverna S; Pucci M; Giallombardo M; Di Bella MA; Santarpia M; Reclusa P; Gil-Bazo I; Rolfo C; Alessandro R
    Sci Rep; 2017 Jun; 7(1):3170. PubMed ID: 28600504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
    Salahudeen AA; Patel MI; Baas P; Curran WJ; Bradley JD; Gandara DR; Goss GD; Mok TS; Ramalingam SS; Vokes EE; Malik SM; Wakelee HA
    Clin Lung Cancer; 2017 Jan; 18(1):5-12. PubMed ID: 27473736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor mutations in nonsmall cell lung carcinoma patients in Kuwait.
    Al-Temaimi R; Kapila K; Al-Mulla FR; Francis IM; Al-Waheeb S; Al-Ayadhy B
    J Cytol; 2016; 33(1):1-6. PubMed ID: 27011433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How and when to use genetic markers for nonsmall cell lung cancer.
    Lazarus DR; Ost DE
    Curr Opin Pulm Med; 2013 Jul; 19(4):331-9. PubMed ID: 23715289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer in the era of targeted therapy: a cytologist's perspective.
    Zakowski MF
    Arch Pathol Lab Med; 2013 Dec; 137(12):1816-21. PubMed ID: 23597048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
    Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
    Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine for non-small-cell lung cancer.
    Mok TS; Zhou Q; Leung L; Loong HH
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1601-11. PubMed ID: 20942631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic non-small cell lung cancer management: novel targets and recent clinical advances.
    Riess JW; Wakelee HA
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):226-34. PubMed ID: 22706483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized targeted therapy in advanced non-small cell lung cancer.
    Ma PC
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS56-60. PubMed ID: 22614968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutations of signaling genes in non-small-cell lung cancer.
    Sanders HR; Albitar M
    Cancer Genet Cytogenet; 2010 Nov; 203(1):7-15. PubMed ID: 20951313
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.